The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease
Trial
N/A
Not yet recruiting
Aug. 4, 2026
Quality-of-Life Index (Q-Index)
Trial
N/A
Completed
Aug. 4, 2026
Towards the Use of Instrumented Tests for Screening the Risk of Falling in Patients With Chronic Illness.
Trial
N/A
Completed
Aug. 4, 2026
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Trial
N/A
Enrolling by invitation
Aug. 4, 2026
Action Observation and Motor Imagery Therapy in Parkinson's Disease
Trial
N/A
Recruiting
Aug. 4, 2026
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease
Trial
N/A
Recruiting
Aug. 3, 2026
Investigation of Exercise Capacity, Muscle Oxygenation and Physical Activity Level in Parkinson's Patients
Trial
N/A
Completed
Aug. 3, 2026
Perceptual Decision Making Under Conditions of Visual Uncertainty
Trial
N/A
Withdrawn
Aug. 3, 2026
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Trial
N/A
Recruiting
Aug. 3, 2026
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Trial
Phase 3
Recruiting
Aug. 3, 2026
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Trial
N/A
Completed
Aug. 3, 2026
Autoimmune Features of Neurodegenerative Disorders
Trial
N/A
Recruiting
Aug. 3, 2026
Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait
Trial
N/A
Completed
Aug. 3, 2026
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Trial
N/A
Recruiting
Aug. 3, 2026
Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease
Trial
N/A
Completed
Aug. 2, 2026
Phase â…¢ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
Trial
Phase 3
Not yet recruiting
Aug. 2, 2026
GBPDC: Gut-Brain in PD Consortium Master Protocol
Trial
N/A
Recruiting
July 30, 2026
ATR 1072 in Participants With PRKAG2 Syndrome
Trial
Phase 1
Not yet recruiting
July 30, 2026